Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Vaccines against Allergies
We are celebrating this year the hundred years ́ anniversary of allergen-specific immunotherapy. In 1911 Leonard Noon published his seminal work “Prophylactic inoculation against hay fever” describing his attempts to achieve active immunity against “grass pollen toxin” by administering increasing doses of grass pollen extract before the grass pollen season to allergic patients. Although it was unknown at that time that allergy represents an immunological hypersensitivity disease, the treatment was effective and many observations made by Noon remained valid until today. Today allergen-specific immunotherapy is well established as the only allergen-specific and disease-modifying treatment for IgE-mediated allergies and has long-lasting effects. In fact, more than 25% of the population suffer from IgE-mediated allergies which therefore represent a major health burden of our society, particularly because untreated allergy often progresses to severe disabling forms of disease, such as asthma and sometimes kills sensitized people through anaphylaxis.
Human Antibodies Against The Dietary Non-Human Neu5Gc-carrying Glycans in Normal and Pathologic States
This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact.
Immunogenicity of Proteins Used as Therapeutics
Topic Editor Susan Richards is an employee of Sanofi and owns stock in the corporation. Topic Editor Bernard Maillere declares economic support from pharmaceutical companies (Novartis, Sanofi, and UCB) in the frame of collaborations aiming to evaluate the recognition by human T cells of therapeutic proteins and antibodies.
Sophie's Troubles
None
Sophie's Story
None
Madame Matisse
This is the story of three women - one an orphan and refugee who finds a place in the studio of a famous French artist, the other a wife and mother who has stood by her husband for nearly forty years. The third is his daughter, caught in the crossfire between her mother and a father she adores. Amelie is first drawn to Henri Matisse as a way of escaping the conventional life expected of her. A free spirit, she sees in this budding young artist a glorious future for them both. Ambitious and driven, she gives everything for her husband's art, ploughing her own desires, her time, her money into sustaining them both, even through years of struggle and disappointment. Lydia Delectorskaya is a you...
Sophie...
This novel, written by Belgian author Virginie Loveling in 1888, tells the story of Sophie, a young woman struggling to find her place in the world. Set against the backdrop of late 19th century Belgium, the book explores themes of love, family, and social class. With its vivid characters, engaging plot, and insightful commentary on the challenges facing women of the time, Sophie is a timeless classic that still resonates with readers today. This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work is in the "public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
